Abstract Submission

Abstract Submission

LINK TO SUBMIT ABSTRACTS

 

The EVF invites you to submit an abstract(s) for consideration of presentation at the EVF 2025 meeting.

Abstracts should be submitted by Friday 14 February 2025 and typed in English. Selection will be based on originality and quality of work. All abstracts will be reviewed and marked blind, by the Scientific Committee. Authors will be notified of the committee’s decision by mid March 2025.

The 30 best abstracts will be selected for oral presentation. The remaining abstracts will be considered for Poster Presentation.

Each abstract should include:

  •   Title
  •   Authors’ names: (Surname, initial)
  •   Presenting author must be indicated.
  •   Institution, City and Country
  •   Type abstract in English. Maximum of 425 words (excluding title, authors’ names, and institution). Abstracts exceeding 425 words will be rejected. Abstracts should include Background/Aim, Methods, Results, Conclusions.

Do not include author’s names or institutions in the abstract body.

  •    All work (clinical studies, RCT etc) should have Ethical Committee approval. The Ethical Committee approval number should be supplied.
  •   References should not be included.
  •   Abstracts must not contain brand or device names. 
  •                   Presenting author must not be a member of a pharmaceutical or device company.
  •                   Indicate if you wish the abstract to be considered for the EVF Prize.
  •                   Have support from the Head of Dept to attend should the abstract be selected.

The official language of the Conference is English. All presentations and discussion will be in English. Abstracts accepted for presentation will be available on the electronic Programme/Book of Abstracts.

EVF Prize – Oral presentations

The EVF prize will be awarded to the three best abstracts according to originality and quality. Please indicate on the Abstract Submission Form if you wish your presentation to be considered for the EVF Prize

To be eligible for the EVF Prize the presenter should:

  • Be a Trainee/Junior Doctor
  • Under 40 years of age
  • Confirm that the material has not been presented or published elsewhere

The top paper (1st place) will present their abstract at the next meeting of the American Venous Forum (AVF). They will receive a grant to a maximum of £1,500 to attend the meeting. The top paper will also present their abstract at the next meeting of the American Vein and Lymphatic Society (AVLS). The AVLS will award a grant towards the expenses. Registration at both meetings will be waived. If you submit your abstract for the EVF Prize, it is expected that you attend the meetings if your abstract is successful.

The abstracts of the top three papers will be sent to the Japanese Society of Phlebology (JSP). They will select one paper to be presented at the 2025 meeting of the JSP. The selected paper will receive a grant from the EVF (to a maximum of €3,000) to attend the meeting. It is expected that the winning paper attends the meeting. The registration fee will be waived.

The winners of the 2nd and 3rd Prize will receive complimentary registration at the next annual meeting of the EVF.

 

EVF Prize – Poster Presentations

The top poster will be awarded the EVF Poster prize for the best poster presentation. The award is free registration at the 2026 meeting of the European Venous Forum.

EVF Grant

Abstracts submitted for the EVF Prize and selected for oral presentation at the meeting will receive an EVF Prize Grant. The presenting author of the paper will receive a grant of up to Euro 500 towards hotel accommodation (3 nights) and travel (economy). The registration fee will be waived.

EVF Abstract Award

The Scientific Committee is pleased to announce the EVF Abstract Award. All papers accepted for oral presentation at the meeting will be considered for the EVF Abstract Award. The papers will be judged on originality and quality of presentation. The winner will receive free registration at the 2026 meeting of the EVF. Note that the three winners of the EVF prize will not be considered for the Award.

IMPORTANT:

It is a condition of submission that should your abstract be accepted for presentation the presenting author will register for the congress at least 4 weeks prior to the date of the meeting. Failure to register will mean removal of your abstract from the programme.

Comments are closed.